ArticleJournal of cellular and molecular medicine2020

miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells.

Rao Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.